Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
lasmiditan
3
×
life sciences
migraine
3
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
cancer immunotherapy
clinical trials
galcanezumab
pfizer
teva pharmaceutical
triptans
abalos therapeutics
acetonid
What
bio
companies
drugs
life
new
roundup
science
approval
arena’s
arguments
bails
big
bounty
brand
bridgebio
capital
car
cig
class
comeback
commercialized
competitors
corner
deals
decades
delivered
develop
drug
emerges
expressing
fda
firm
grab
headlines
ichnos
invest
ipo
little
make
meeting
Language
unset
Current search:
migraine
×
lasmiditan
×
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
